Jump to content

Lotronex for IBS-D restricted access removed by the FDA

Recommended Posts

Jeffrey Roberts

An update from the FDA on the medication for IBS-D called Lotronex (alosetron hydrochloride) which is only marketed in the US.

Lotronex and approved generics are FDA approved for the treatment of irritable bowel syndrome in women whose predominant bowel symptom is diarrhea.

Although safety risks for Lotronex (alosetron hydrochloride) and approved generics still exist, FDA has determined the risk evaluation and mitigation strategies (REMS) programs for these drugs ARE NO LONGER NECESSARY to ensure the benefits outweigh the risks of ischemic colitis and serious complications of constipation.



Aside:  In 2002, myself & 10 other IBS patients testified at the FDA asking for Lotronex to be returned to the market as we deemed it safe if prescribed correctly. Fast forward 21 years and restricted access of a very well tolerated medication for IBS-D has been lifted. Thank you to the FDA.

Link to comment
Share on other sites

  • 1 month later...
Jeffrey Roberts
On 9/20/2023 at 8:17 AM, danb said:

Good news. I wonder what caused them to reevaluate their decision.

I believe there were no new adverse events reported that continued to require the guidance.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...